BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/19/2025 3:42:07 AM | Browse: 14 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 107361
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation
Manuscript Source Unsolicited Manuscript
All Author List Hua-Yue Wu, Lu Han, Tao Ran, Yong Sun, Qing-Xiu Zhang, Tao Huang, Gao-Liang Zou, Ya Zhang, Yu-Mei Zhou, Guo-Yuan Lin, Shao-Jie Chen, Jing-Lin Wang, Chen Pan, Fan Lu, Hong-Fei Pu and Xue-Ke Zhao
Funding Agency and Grant Number
Funding Agency Grant Number
the Science and Technology Program of the Guizhou Province [2021]094
National Natural Science Foundation of China 82060116
the Guizhou Provincial Science and Technology Program QKHJC-ZK[2023]214
Doctoral Research Start-up Fund Project of Guizhou Medical University gyfybsky[2021]63
National Natural Science Foundation of China 82260129
Corresponding Author Xue-Ke Zhao, MD, Department of Infectious Diseases, Affiliated Hospital of Guizhou Medical University,Guizhou Medical University, No. 9 Beijing Road, Guiyang 550004, Guizhou Province, China. zhaoxueke1@163.com
Key Words Liver fibrosis; Hepatic stellate cells; Focal adhesion kinase; Aerobic glycolysis; Fructose-1,6-bisphosphatase
Core Tip In this study, we show that focal adhesion kinase (FAK) inhibitors suppress hepatic stellate cells (HSCs) activation and aerobic glycolysis, thereby alleviating liver fibrosis (LF). FBP1 inhibits HSCs activation and migration by regulating aerobic glycolysis. FAK can affect the expression of FBP1. Therefore, both FAK and FBP1 may serve as potential therapeutic targets for LF.
Citation Wu HY, Han L, Ran T, Sun Y, Zhang QX, Huang T, Zou GL, Zhang Y, Zhou YM, Lin GY, Chen SJ, Wang JL, Pan C, Lu F, Pu HF, Zhao XK. FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation. World J Gastroenterol 2025; In press
Received
2025-03-21 16:13
Peer-Review Started
2025-03-21 16:13
To Make the First Decision
Return for Revision
2025-04-20 03:57
Revised
2025-04-29 09:28
Second Decision
2025-06-19 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-06-19 03:42
Articles in Press
2025-06-19 03:42
Publication Fee Transferred
2025-04-30 07:08
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com